Big biotech, UCs launch $53M effort targeting Alzheimer’s, other brain diseases

UCSF and UC Berkeley will receive $53 million over 10 years as part of a collaboration with biotech giant Genentech Inc. and its Swiss parent Roche to research potential new treatments for Alzheimer's, Huntington's and Parkinson's diseases, ALS, autism and other central nervous system conditions. The partnership builds on a University of California-University of Washington effort started in 2019 and backed by the foundation of former Citibank CEO Sandy Weill and his wife, Joan, and it will initially…

Click to view original post